Posts by KCAS Bio
February 24
- February 26
KCAS Bio is excited to announce our attendance at the 16th Open Scientific EIP (European Immunogenicity Platform) Symposium, taking place in Lisbon, Portugal, from February 24-26, 2025. This premier event brings together global leaders in immunogenicity to share insights, exchange ideas, and drive innovation in the development of biologics and…
February 19
- February 22
KCAS Bio is proud to announce our participation in the 20th Congress of ECCO (European Crohn’s and Colitis Organisation), taking place in Berlin, Germany, from February 19-22, 2025. This prestigious event brings together global experts, researchers, and clinicians dedicated to improving the understanding and treatment of inflammatory bowel diseases (IBD).
March 16
- March 20
KCAS Bio is excited to announce our participation in the Society of Toxicology (SOT) Annual Meeting and ToxExpo, taking place in Orlando, Florida on March 16th-20th. As one of the largest gatherings of toxicologists and life sciences professionals, this event offers a unique platform to connect with leaders in toxicology…
Blogs
Dose Formulation Analysis is an essential step in regulated nonclinical studies. Robust analytical methods, rapid turnaround, and efficient communication helps ensure the dose form results for your GLP studies are delivered on time. At KCAS Bio, our scientific expertise allows us to develop methods that achieve…
Blogs
As the bioanalytical market evolves at a rapid pace, KCAS Bio stands at the forefront, offering an innovative approach to challenges and opportunities alike. Drawing on the insights of our leadership team, we’ve compiled a global perspective on the state of the bioanalytical industry in 2024. Through thoughtful discussions with…
Blogs
Drawing on the insights of our leadership team, we’ve compiled a global perspective on the state of the bioanalytical industry in 2024. Through thoughtful discussions with our CEO, John Bucksath, and key team members Amy Mize, Mouhssin Oufir, and Brian Wile, KCAS Bio delivers a roadmap…
Blogs
Drawing on the insights of our leadership team, we’ve compiled a global perspective on the state of the bioanalytical industry in 2024. Through thoughtful discussions with our CEO, John Bucksath, and key team members Amy Mize, Mouhssin Oufir, and Brian Wile, KCAS Bio delivers a roadmap…
December 10
- December 10
KCAS Bio is excited to sponsor the upcoming Pharmaceutical & BioScience Society (PBSS) workshop “Antibody-Drug Conjugates from Discovery to Development: Chemistry, Engineering, Characterization, CMC, PK/Tox, Clinical Design and Intellectual Property,” on December 10th from 8:45am – 5:30pm PST in San Diego, California at the Hyatt Regency – La Jolla. Showcasing…
Posters & Papers
This infographic explores the key trends in flow cytometry, software and instrumentation based on results from a recent Spotlight survey. It highlights the top challenges for biomarker analysis using flow cytometry, including lack of standardized control materials, sourcing a suitable laboratory and uncertain regulatory expectation, as well as what the…
Posters & Papers
Please download this poster, “Validation of a 15-Color Spectral Flow Cytometry Panel for Globally Harmonized Comprehensive Leukocyte Profiling in Human Whole Blood: Translational and Clinical Applications “ CYTEK_ValidatedPanels_EBF2024_20241118Download…
Posters & Papers
Please download this poster, “Comparative Evaluation of Ligand Binding Assay Platforms for BiomarkerQuantification: Critical Considerations for Ensuring Data Quality and Project Success” LBAPlatforms_EBF2024_Poster_vfDownload…
January 13
- January 16
KCAS Bio is thrilled to announce our attendance at the upcoming J.P. Morgan Healthcare Conference, a premier gathering that draws top leaders, decision-makers, and innovators from across the life sciences and healthcare industries. As we join this influential event in San Francisco, KCAS Bio is eager to connect with industry…